Accredited Investors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,520
Closed -$218K 178
2022
Q1
$218K Hold
9,520
0.02% 168
2021
Q4
$263K Hold
9,520
0.02% 154
2021
Q3
$265K Hold
9,520
0.03% 144
2021
Q2
$279K Hold
9,520
0.03% 139
2021
Q1
$302K Buy
+9,520
New +$279K 0.04% 125
2020
Q1
Sell
-9,520
Closed -$285K 131
2019
Q4
$285K Hold
9,520
0.05% 114
2019
Q3
$208K Sell
9,520
-945
-9% -$21.6K 0.04% 128
2019
Q2
$264K Buy
+10,465
New +$248K 0.05% 114

Other funds holding BHC

Accredited Investors's BHC Position: Q2 2022 in Review

Accredited Investors sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 9,520 shares — an estimated $218K sold.

Accredited Investors first reported a position in BHC in Q2 2019 and held it in 8 quarters. The position peaked at $302K in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Accredited Investors reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Accredited Investors sold 9,520 Bausch Health shares in Q2 2022, an estimated $218K.
  • Accredited Investors first reported a position in Bausch Health in Q2 2019 and held it in 8 quarters.
  • Accredited Investors's Bausch Health position peaked at $302K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Accredited Investors's 13F filing for Q2 2022, filed 21 Jul 2022.